Browsing Tag

Tempol

Adamis Pharmaceuticals Announces Results of Tempol in Omicron Virus Challenge in…

Eli Pacheco Mar 22, 2022 0

SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) today announced that in studies conducted at Galveston National Laboratory (GNL),…

Health

Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the…

Eli Pacheco Mar 14, 2022 0

SAN DIEGO, March 14, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) today announced that on March 11, 2022, the Data Safety Monitoring Board (DSMB) overseeing…

Health

Adamis Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides…

Eli Pacheco Nov 23, 2021 0

SAN DIEGO, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy,…

Health

Adamis Provides Update on Clinical Trial Start-Up Progress for Tempol in the…

Eli Pacheco Jun 11, 2021 0

SAN DIEGO, June 11, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that clinical trial start-up activities are underway for examining the…